Growth Metrics

Edwards Lifesciences (EW) Long-Term Deferred Tax (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Long-Term Deferred Tax data on record, last reported at $1.1 billion in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 23.81% year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $1.1 billion, up 23.81%, while the annual FY2024 figure was $992.1 million, 32.39% up from the prior year.
  • Long-Term Deferred Tax reached $1.1 billion in Q3 2025 per EW's latest filing, up from $1.1 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $1.1 billion in Q3 2025 and bottomed at $184.0 million in Q3 2021.
  • Average Long-Term Deferred Tax over 5 years is $606.3 million, with a median of $610.7 million recorded in 2023.
  • Peak YoY movement for Long-Term Deferred Tax: decreased 14.5% in 2021, then surged 98.54% in 2023.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $246.7 million in 2021, then soared by 96.19% to $484.0 million in 2022, then skyrocketed by 54.83% to $749.4 million in 2023, then soared by 32.39% to $992.1 million in 2024, then grew by 10.87% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $1.1 billion in Q3 2025, $1.1 billion in Q2 2025, and $1.0 billion in Q1 2025.